학술논문

LuNER: Multiplexed SARS-CoV-2 detection in clinical swab and wastewater samples
Document Type
article
Source
PLOS ONE. 16(11)
Subject
Genetic Testing
Vaccine Related
Biodefense
Genetics
Biotechnology
Prevention
Infectious Diseases
Lung
Emerging Infectious Diseases
Detection
screening and diagnosis
4.2 Evaluation of markers and technologies
Infection
Good Health and Well Being
COVID-19
DNA Primers
Humans
RNA
Viral
Real-Time Polymerase Chain Reaction
Ribonuclease P
SARS-CoV-2
Sensitivity and Specificity
Specimen Handling
Wastewater
Wastewater-Based Epidemiological Monitoring
IGI Testing Consortium
General Science & Technology
Language
Abstract
Clinical and surveillance testing for the SARS-CoV-2 virus relies overwhelmingly on RT-qPCR-based diagnostics, yet several popular assays require 2-3 separate reactions or rely on detection of a single viral target, which adds significant time, cost, and risk of false-negative results. Furthermore, multiplexed RT-qPCR tests that detect at least two SARS-CoV-2 genes in a single reaction are typically not affordable for large scale clinical surveillance or adaptable to multiple PCR machines and plate layouts. We developed a RT-qPCR assay using the Luna Probe Universal One-Step RT-qPCR master mix with publicly available primers and probes to detect SARS-CoV-2 N gene, E gene, and human RNase P (LuNER) to address these shortcomings and meet the testing demands of a university campus and the local community. This cost-effective test is compatible with BioRad or Applied Biosystems qPCR machines, in 96 and 384-well formats, with or without sample pooling, and has a detection sensitivity suitable for both clinical reporting and wastewater surveillance efforts.